The use of Temgesic in combination with exposure therapy to treat social anxiety symptoms.

This study is testing whether a medication called Temgesic (buprenorphine, a low-dose pain and anxiety reliever) can improve the results of exposure therapy for social anxiety. Social phobia causes intense fear and avoidance of social situations such as speaking in public, meeting new people, or being watched by others. Participants will attend five weekly group therapy sessions and take either Temgesic or a placebo before public speaking exercises. One month after the program ends, their anxiety levels will be measured to see if Temgesic helped them overcome their fear more effectively. You may be eligible if: - You are an adult (18 years or older) - Your primary (main) diagnosis is social phobia (social anxiety disorder) You may NOT be eligible if: - You have significant liver or kidney problems - You have impaired breathing or a breathing condition - You have had a head injury - You have a substance abuse or dependence problem Talk to your doctor about whether this trial might be right for you.